doi: 10.3389/fmolb.2023.1130625 Received 28 December 2022 Accepted 08 May 2023 Published 23 May 2023 Volume 10 - 2023 Edited by Hem Chandra Jha, Indian Institute of Technology Indore, India Reviewed by Finbarr P
Accordingly, a reduced caloric intake has been observed in lean and obese individuals and in patients with T2D after exogenously administered GLP-1 during ad libitum meals
Longer treatment durations up to several months have been examined in chronic disease models without apparent tolerance development or diminishing efficacy
Newer labels such as Tirzepatide also warn about pulmonary aspiration risk during anesthesia because these drugs can delay stomach emptying [15]
Whether one treatment is sufficient or additional sessions are recommended, you can trust Sassy Med Spa will be your dedicated partner in reaching your desired outcome
(PubMed) Knekt P, Ritz J, Pereira MA, et al